PARP4 and melanoma: Our results have suggested that the knockdown of PARP4 could reduce the repair efficiency of the NHEJ pathway, prompting us to investigate whether melanoma cells with low PARP4 expression were more sensitive to DNA damage repair inhibitors based on the synthetic lethal strategy.